What is a stock summary page? Click here for an overview.
Business Description
bluebird bio Inc
NAICS : 325414
SIC : 2836
ISIN : US09609G1004
Share Class Description:
BLUE: Ordinary SharesDescription
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing, and commercializing potentially transformative gene therapies for severe genetic diseases.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.17 | |||||
| Equity-to-Asset | -0.07 | |||||
| Debt-to-Equity | -11.36 | |||||
| Debt-to-EBITDA | -2.27 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -15.46 | |||||
| Beneish M-Score | -1.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 101.1 | |||||
| 3-Year EBITDA Growth Rate | 53.2 | |||||
| 3-Year EPS without NRI Growth Rate | 46.2 | |||||
| 3-Year FCF Growth Rate | 47.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 39.6 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 53.56 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.75 | |||||
| 9-Day RSI | 65.11 | |||||
| 14-Day RSI | 56.41 | |||||
| 3-1 Month Momentum % | -57.73 | |||||
| 6-1 Month Momentum % | -62.55 | |||||
| 12-1 Month Momentum % | -83.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.48 | |||||
| Quick Ratio | 0.28 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 167.85 | |||||
| Days Sales Outstanding | 73.09 | |||||
| Days Payable | 103.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -39.9 | |||||
| Shareholder Yield % | -167.47 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -6.65 | |||||
| Operating Margin % | -319.42 | |||||
| Net Margin % | -287.23 | |||||
| FCF Margin % | -313.36 | |||||
| ROE % | -352.71 | |||||
| ROA % | -44.23 | |||||
| ROIC % | -50.12 | |||||
| 3-Year ROIIC % | 157.48 | |||||
| ROC (Joel Greenblatt) % | -83.92 | |||||
| ROCE % | -83.4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.56 | |||||
| EV-to-EBIT | -1.57 | |||||
| EV-to-EBITDA | -2.18 | |||||
| EV-to-Revenue | 4.1 | |||||
| EV-to-Forward-Revenue | 2.11 | |||||
| EV-to-FCF | -1.31 | |||||
| Price-to-GF-Value | 0.01 | |||||
| Earnings Yield (Greenblatt) % | -63.69 | |||||
| FCF Yield % | -541.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BLUE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
bluebird bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 83.807 | ||
| EPS (TTM) ($) | -24.64 | ||
| Beta | 0.07 | ||
| 3-Year Sharpe Ratio | -0.79 | ||
| 3-Year Sortino Ratio | -0.95 | ||
| Volatility % | 80.2 | ||
| 14-Day RSI | 56.41 | ||
| 14-Day ATR ($) | 0.428252 | ||
| 20-Day SMA ($) | 4.1195 | ||
| 12-1 Month Momentum % | -83.56 | ||
| 52-Week Range ($) | 3.56 - 28.6 | ||
| Shares Outstanding (Mil) | 9.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
bluebird bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
bluebird bio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
bluebird bio Inc Frequently Asked Questions
What is bluebird bio Inc(BLUE)'s stock price today?
The current price of BLUE is $4.95. The 52 week high of BLUE is $28.60 and 52 week low is $3.56.
When is next earnings date of bluebird bio Inc(BLUE)?
The next earnings date of bluebird bio Inc(BLUE) is 2025-05-09 Est..
Does bluebird bio Inc(BLUE) pay dividends? If so, how much?
bluebird bio Inc(BLUE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers